Allopurinol does not improve cardiovascular outcomes in ischemic heart disease patients
The gout medicine allopurinol has failed to reduce the primary endpoint of nonfatal myocardial infarction, nonfatal stroke or cardiovascular death in patients with ischemic heart disease, according to late breaking research ...
Aug 29, 2022
0
0